Latest IR information
IR News
- 2024.12.13
- Research Results on the Antitumor Effects of Intravenous Brincidofovir and its Potential Use as a Therapy in Combination with Immune Checkpoint Inhibitors to be Presented at the 66th Annual Meeting of the American Society of Hematology
- 2024.11.20
- SymBio Presents Research Results Showing Potential Use of Intravenous Brincidofovir in Combination with Immune Checkpoint Inhibitors as a Therapy for Malignant Lymphoma at the 66th the American Society of Hematology Annual Meeting
- 2024.11.05
- Notice of Appointment of Corporate Vice President and Global CMO
- 2024.10.31
- Summary of Consolidated Financial Statements for the First Nine Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]
- 2024.10.23
- SymBio presents data from Phase IIa clinical trial showing clinical efficacy of IV BCV in treating symptoms of adenovirus infection